QuidelOrtho
QDEL
#6435
Rank
HK$7.22 B
Marketcap
HK$105.31
Share price
8.14%
Change (1 day)
-51.77%
Change (1 year)
Quidel is an American manufacturer of diagnostics testings that can be used to diagnose infectious diseases as well as cardiovascular and metabolic diseases.

P/S ratio for QuidelOrtho (QDEL)

P/S ratio as of October 2026 (TTM): 0.3493

According to QuidelOrtho's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.5262. At the end of 2026 the company had a P/S ratio of 0.3516.

P/S ratio history for QuidelOrtho from 2001 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20260.3516-50.89%
20250.7161-33.04%
20241.07-34.9%
20231.64-5.18%
20221.73-47.71%
20213.31-27.16%
20204.55-22.56%
20195.8759.52%
20183.68-30.62%
20175.3145.4%
20163.651.32%
20153.60-33.82%
20145.44-9.29%
20136.0049.63%
20124.0126.43%
20113.17-12.75%
20103.6449.31%
20092.43-26.67%
20083.32-38.44%
20075.3925.21%
20064.318.99%
20053.9589.8%
20042.08-39.52%
20033.44162.06%
20021.31-56.4%
20013.01

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Thermo Fisher Scientific
TMO
5.27 1,409.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
2.39 585.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
6.17 1,665.38%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
4.31 1,132.77%๐Ÿ‡บ๐Ÿ‡ธ USA
OraSure Technologies
OSUR
2.40 586.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Meridian Bioscience
VIVO.defunct
4.47 1,180.05%๐Ÿ‡บ๐Ÿ‡ธ USA